These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. [Ovulation inhibitors also for patients with liver diseases?]. Runnebaum B Munch Med Wochenschr; 1972 May; 114(21):1036-8. PubMed ID: 5068334 [No Abstract] [Full Text] [Related]
66. Environmental exposure assessment of ethinyl estradiol (EE) from a combined hormonal vaginal contraceptive ring after disposal; leaching from landfills. Geurts MG; de Boer W; de Graaf JS; van Ginkel CG Sci Total Environ; 2007 May; 377(2-3):366-70. PubMed ID: 17368514 [TBL] [Abstract][Full Text] [Related]
67. Hormonal contraception: recent advances and controversies. Practice Committee of American Society for Reproductive Medicine Fertil Steril; 2008 Nov; 90(5 Suppl):S103-13. PubMed ID: 19007605 [TBL] [Abstract][Full Text] [Related]
68. Current contraceptive research and development. Reape KZ Adolesc Med Clin; 2005 Oct; 16(3):617-33. PubMed ID: 16183543 [TBL] [Abstract][Full Text] [Related]
70. FDA notifications. Final rule is out on OTC vaginal contraceptives and spermicides. AIDS Alert; 2008 Feb; 23(2):22-3. PubMed ID: 18574883 [No Abstract] [Full Text] [Related]
71. Contraceptive patch and vaginal ring vs. combined oral contraceptives. Meyer S Am Fam Physician; 2009 Aug; 80(3):232. PubMed ID: 19621832 [No Abstract] [Full Text] [Related]
72. Parenteral administration of progestins for hormonal replacement therapy. Nath A; Sitruk-Ware R Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):88-96. PubMed ID: 19340703 [TBL] [Abstract][Full Text] [Related]
73. [Present and future choices of vaginal drug dosage forms. I. Classical forms]. Guyot M; Fawaz F J Pharm Belg; 1993; 48(5):393-406. PubMed ID: 8120794 [TBL] [Abstract][Full Text] [Related]
74. [Prolonged effect of contraceptive steroids in experiment]. Cekan Z; Kincl FA Cesk Gynekol; 1967 Apr; 32(3):181-3. PubMed ID: 6082986 [No Abstract] [Full Text] [Related]
75. Inhibition of ovulation with cyclic use of progestogen-impregnated intravaginal devices. Mishell DR; Lumkin M; Stone S Am J Obstet Gynecol; 1972 Aug; 113(7):927-32. PubMed ID: 4635742 [No Abstract] [Full Text] [Related]
76. A scanning electron microscopic study of the contraceptive vaginal ring. Miller L; MacFarlane SA; Materi HL Contraception; 2005 Jan; 71(1):65-7. PubMed ID: 15639076 [TBL] [Abstract][Full Text] [Related]
77. SPERMICIDAL times of contraceptive jellies and creams, 1949. J Am Med Assoc; 1951 Jan; 145(1):50-5. PubMed ID: 14880465 [No Abstract] [Full Text] [Related]
78. Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). Camacho DP; Consolaro ME; Patussi EV; Donatti L; Gasparetto A; Svidzinski TI Contraception; 2007 Dec; 76(6):439-43. PubMed ID: 18061701 [TBL] [Abstract][Full Text] [Related]
79. Bleeding patterns of women using extended regimens of the contraceptive vaginal ring. Barreiros FA; Guazzelli CA; de Araújo FF; Barbosa R Contraception; 2007 Mar; 75(3):204-8. PubMed ID: 17303490 [TBL] [Abstract][Full Text] [Related]